"Adenoviridae" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of non-enveloped viruses infecting mammals (MASTADENOVIRUS) and birds (AVIADENOVIRUS) or both (ATADENOVIRUS). Infections may be asymptomatic or result in a variety of diseases.
| Descriptor ID |
D000256
|
| MeSH Number(s) |
B04.280.030
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Adenoviridae".
Below are MeSH descriptors whose meaning is more specific than "Adenoviridae".
This graph shows the total number of publications written about "Adenoviridae" by people in this website by year, and whether "Adenoviridae" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 8 | 6 | 14 |
| 1992 | 14 | 10 | 24 |
| 1993 | 10 | 6 | 16 |
| 1994 | 17 | 6 | 23 |
| 1995 | 33 | 19 | 52 |
| 1996 | 27 | 23 | 50 |
| 1997 | 40 | 36 | 76 |
| 1998 | 47 | 40 | 87 |
| 1999 | 50 | 46 | 96 |
| 2000 | 53 | 69 | 122 |
| 2001 | 58 | 62 | 120 |
| 2002 | 227 | 324 | 551 |
| 2003 | 232 | 379 | 611 |
| 2004 | 217 | 385 | 602 |
| 2005 | 227 | 364 | 591 |
| 2006 | 219 | 306 | 525 |
| 2007 | 250 | 257 | 507 |
| 2008 | 247 | 307 | 554 |
| 2009 | 255 | 254 | 509 |
| 2010 | 198 | 248 | 446 |
| 2011 | 204 | 277 | 481 |
| 2012 | 222 | 214 | 436 |
| 2013 | 186 | 225 | 411 |
| 2014 | 182 | 203 | 385 |
| 2015 | 148 | 160 | 308 |
| 2016 | 143 | 172 | 315 |
| 2017 | 113 | 146 | 259 |
| 2018 | 103 | 131 | 234 |
| 2019 | 32 | 41 | 73 |
| 2020 | 3 | 27 | 30 |
| 2021 | 2 | 8 | 10 |
To return to the timeline, click here.
Below are the most recent publications written about "Adenoviridae" by people in Profiles.
-
Audio Interview: Efficacy of Current Covid-19 Vaccines against Variant Viruses. N Engl J Med. 2021 03 18; 384(11):e53.
-
Novel approaches for vaccine development. Cell. 2021 03 18; 184(6):1589-1603.
-
Audio Interview: A New SARS-CoV-2 Vaccine and a New Look at Treatment. N Engl J Med. 2021 Mar 04; 384(9):e46.
-
Capsid and Genome Modification Strategies to Reduce the Immunogenicity of Adenoviral Vectors. Int J Mol Sci. 2021 Feb 28; 22(5).
-
Viral Vectors for COVID-19 Vaccine Development. Viruses. 2021 02 19; 13(2).
-
Development of a Broadly Applicable Cas12a-Linked Beam Unlocking Reaction for Sensitive and Specific Detection of Respiratory Pathogens Including SARS-CoV-2. ACS Chem Biol. 2021 03 19; 16(3):491-500.
-
What We Do Know and Do Not Yet Know about COVID-19 Vaccines as of the Beginning of the Year 2021. J Korean Med Sci. 2021 Feb 08; 36(6):e54.
-
Audio Interview: Covid-19 and the States - A Conversation with Ralph Northam. N Engl J Med. 2021 Feb 04; 384(5):e25.
-
Industry Update: the latest developments in the field of therapeutic delivery, September 2020. Ther Deliv. 2021 01; 12(1):7-20.
-
Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection. Am J Respir Cell Mol Biol. 2021 01; 64(1):79-88.